Global Imidacloprid (CAS 138261-41-3) Market Outlook 2016-2021

Published: Sep, 2016 | Pages: 101 | Publisher: Gen Consulting Company
Industry: Chemicals | Report Format: Electronic (PDF)

Imidacloprid is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids which act on the central nervous system of insects, with much lower toxicity to mammals. The chemical works by interfering with the transmission of stimuli in the insect nervous system. Specifically, it causes a blockage of the nicotinergic neuronal pathway. By blocking nicotinic acetylcholine receptors, imidacloprid prevents acetylcholine from transmitting impulses between nerves, resulting in the insect's paralysis and eventual death. It is effective on contact and via stomach action. Because imidacloprid binds much more strongly to insect neuron receptors than to mammal neuron receptors, this insecticide is more toxic to insects than to mammals.

As of 1999, Imidacloprid was the most widely used insecticide in the world. Although it is now off patent, the primary manufacturer of this chemical is Bayer CropScience (part of Bayer AG). It is sold under many names for many uses; it can be applied by soil injection, tree injection, application to the skin of the plant, broadcast foliar, ground application as a granular or liquid formulation, or as a pesticide-coated seed treatment. Imidacloprid is widely used for pest control in agriculture. Other uses include application to foundations to prevent termite damage, pest control for gardens and turf, treatment of domestic pets to control fleas, protection of trees from boring insects, and in preservative treatment of some types of lumber products (e.g., Ecolife brand).

Recent research suggests that widespread agricultural use of imidacloprid and other pesticides may be contributing to honey bee colony collapse disorder, the decline of honey bee colonies in Europe and North America observed since 2006. As a result, several countries have restricted use of imidacloprid and other neonicotinoids. In January 2013, the European Food Safety Authority stated that neonicotinoids pose an unacceptably high risk to bees, and that the industry-sponsored science upon which regulatory agencies' claims of safety have relied, may be flawed, or even deceptive.

This report provides detailed analysis of worldwide markets for Imidacloprid (CAS 138261-41-3) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Imidacloprid (CAS 138261-41-3) market and further lays out an analysis of the factors influencing the supply/demand for Imidacloprid (CAS 138261-41-3), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Imidacloprid (CAS 138261-41-3) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Imidacloprid (CAS 138261-41-3) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Imidacloprid (CAS 138261-41-3) market are Bayer (Germany), Meghmani Organics (India), Atul Ltd (India), PCCPL (India), Sudarshan (India), BCIL (India), KWIN (China), Hailir (China), Jiangsu Changqing (China), Jiangsu Changlong (China), Ningbo Sunjoy Agroscience (China), Sino-Agri Union (China), Fengshan (China), Red Sun (China), Anhui Huaxing Chemical (China) , among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Imidacloprid (CAS 138261-41-3) industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Imidacloprid (CAS 138261-41-3) Production Volume (Unit) 2011-2016
Figure Global Imidacloprid (CAS 138261-41-3) Production Value (M USD) 2011-2016
Figure Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Volume Share 2015
Figure Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value Share 2015
Figure Regional Imidacloprid (CAS 138261-41-3) Production (Unit) 2015
Figure Regional Imidacloprid (CAS 138261-41-3) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Imidacloprid (CAS 138261-41-3) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Imidacloprid (CAS 138261-41-3) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Imidacloprid (CAS 138261-41-3) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Imidacloprid (CAS 138261-41-3) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Imidacloprid (CAS 138261-41-3) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Imidacloprid (CAS 138261-41-3) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Imidacloprid (CAS 138261-41-3) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Imidacloprid (CAS 138261-41-3) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Imidacloprid (CAS 138261-41-3) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Imidacloprid (CAS 138261-41-3) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Imidacloprid (CAS 138261-41-3) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2011-2016
Table Global Key Imidacloprid (CAS 138261-41-3) Vendors Production Share 2011-2016
Figure Global Imidacloprid (CAS 138261-41-3) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2011-2016
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2011
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2012
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2013
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2014
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2015
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production (Unit) 2016
Figure Imidacloprid (CAS 138261-41-3) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Imidacloprid (CAS 138261-41-3) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Imidacloprid (CAS 138261-41-3) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Imidacloprid (CAS 138261-41-3) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Imidacloprid (CAS 138261-41-3) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Imidacloprid (CAS 138261-41-3) Production Value (M USD), Growth Rate
Table Global Key Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2011-2016
Table Global Key Imidacloprid (CAS 138261-41-3) Vendors Production Value Share 2011-2016
Figure Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2011
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2012
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2013
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2014
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2015
Table Global Top 10 Imidacloprid (CAS 138261-41-3) Vendors Production Value (M USD) 2016
Figure Imidacloprid (CAS 138261-41-3) Prices (USD/Ton) 2016
Figure Imidacloprid (CAS 138261-41-3) Gross Margin 2016
Figure Imidacloprid (CAS 138261-41-3) Production Value (M USD) By Region 2011-2016
Table Global Imidacloprid (CAS 138261-41-3) Production Value (M USD) 2011-2016
Table Global Imidacloprid (CAS 138261-41-3) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Imidacloprid (CAS 138261-41-3) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Imidacloprid (CAS 138261-41-3) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Imidacloprid (CAS 138261-41-3) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Imidacloprid (CAS 138261-41-3) Production Value Share Trend
Figure Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2015
Table Regional Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2011-2016
Table Regional Imidacloprid (CAS 138261-41-3) Consumption Volume Share 2011-2016
Figure Imidacloprid (CAS 138261-41-3) Consumption in North America 2011-2016
Figure Imidacloprid (CAS 138261-41-3) Consumption in EMEA 2011-2016
Figure Imidacloprid (CAS 138261-41-3) Consumption in Asia-Pacific 2011-2016
Figure Imidacloprid (CAS 138261-41-3) Consumption in ROW 2011-2016
Figure Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2016
Table Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2011-2016
Table Global Imidacloprid (CAS 138261-41-3) Consumption Volume Share 2011-2016
Figure Global Imidacloprid (CAS 138261-41-3) Production (Unit) Forecast 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Production (Unit) 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Production Share 2016-2021
Figure North Imidacloprid (CAS 138261-41-3) Production (Unit) Forecast 2016-2021
Figure EMEA Imidacloprid (CAS 138261-41-3) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Imidacloprid (CAS 138261-41-3) Production (Unit) Forecast 2016-2021
Figure ROW Imidacloprid (CAS 138261-41-3) Production (Unit) Forecast 2016-2021
Figure Global Imidacloprid (CAS 138261-41-3) Revenue (M USD) Forecast 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Revenue (M USD) 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Revenue Share 2016-2021
Figure North America Imidacloprid (CAS 138261-41-3) Revenue (M USD) Forecast 2016-2021
Figure EMEA Imidacloprid (CAS 138261-41-3) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Imidacloprid (CAS 138261-41-3) Revenue (M USD) Forecast 2016-2021
Figure ROW Imidacloprid (CAS 138261-41-3) Revenue (M USD) Forecast 2016-2021
Figure Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Consumption Volume Share 2016-2021
Figure North America Imidacloprid (CAS 138261-41-3) Consumption (Unit) Forecast
Figure EMEA Imidacloprid (CAS 138261-41-3) Consumption (Unit) Forecast
Figure Asia-Pacific Imidacloprid (CAS 138261-41-3) Consumption (Unit) Forecast
Figure ROW Imidacloprid (CAS 138261-41-3) Consumption (Unit) Forecast
Figure Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2021
Table Global Imidacloprid (CAS 138261-41-3) Consumption Volume (Unit) 2016-2021
Table Global Imidacloprid (CAS 138261-41-3) Consumption Volume Share 2016-2021
Table Key Strategies for Imidacloprid (CAS 138261-41-3) Multinational Corporations
Table Key Strategies for Imidacloprid (CAS 138261-41-3) Emerging-Market Players